Concepedia

Method comparison of dipeptidyl peptidase IV activity assays and their application in biological samples containing reversible inhibitors

Veerle Matheeussen, Anne‐Marie Lambeir, Wolfgang Jungraithmayr, Nelson Gomez, Kathleen Mc Entee, Pieter Van der Veken, Simon Scharpé, Ingrid De Meester

Clinica Chimica Acta · 2011 · 81 citations · 38 references

DOI

Concepts

References

38

STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT

J Martin Bland, DouglasG. Altman · The Lancet · 1986 · 47.6K citations

, , +7

Akufo and Ibarapa

A H BECKETT, M ROWLAND, P TURNER · The Lancet · 1965 · 16.9K citations

(2<i>R</i>)-4-Oxo-4-[3-(Trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-<i>a</i>]pyrazin- 7(8<i>H</i>)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine:  A Potent, Orally Active Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 Diabetes

Dooseop Kim, Liping Wang, Maria Beconi et al. · Journal of Medicinal Chemistry · 2004 · 817 citations · Full text

, , +15

Discovery and Preclinical Profile of Saxagliptin (BMS-477118):  A Highly Potent, Long-Acting, Orally Active Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 Diabetes

David J. Augeri, Jeffrey A. Robl, David A. Betebenner et al. · Journal of Medicinal Chemistry · 2005 · 621 citations · Full text

, , +10

1-[[(3-Hydroxy-1-adamantyl)amino]acetyl]-2-cyano-(<i>S</i>)-pyrrolidine:  A Potent, Selective, and Orally Bioavailable Dipeptidyl Peptidase IV Inhibitor with Antihyperglycemic Properties

Edwin B. Villhauer, J. A. Brinkman, Goli B. Naderi et al. · Journal of Medicinal Chemistry · 2003 · 613 citations · Full text

, , +12